시장보고서
상품코드
1441209

세계의 심장 펌프 기기 시장 규모, 점유율, 성장 분석, 제품 유형별, 적응증별, 최종 사용자별 - 산업 예측(2023-2030년)

Global Heart Pump Device Market Size, Share, Growth Analysis, By Product Type(Ventricular assist devices, Intra-aortic balloon pumps ), By Indication(Bridge-to-transplant, Destination therapy ), By End-user - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심장 펌프 기기 시장 규모는 2022년 20억 9,000만 달러로 평가되었고, 예측 기간(2024-2031년) 동안 24.77%의 연평균 복합 성장률(CAGR)로 2023년 26억 1,000만 달러에서 2031년에는 153억 2,000만 달러로 성장할 것으로 예상됩니다.

세계 심장 펌프 기기 시장은 전 세계적으로 상당한 성장세를 보이고 있습니다. 이 보고서는 심장 펌프 기기 시장의 밸류체인 분석에 대한 자세한 정보를 다루고 예측 기간 동안 경쟁 우위를 점할 수 있는 경쟁적 고려 사항을 제조업체에 제공합니다. 시장 성장의 주요 원동력은 전 세계적으로 심혈관 질환의 유병률 증가입니다. 심부전 유병률이 계속 증가함에 따라 중증 심장병 환자의 심장 기능을 지원하고 유지하는 데 중요한 역할을 하는 심장 펌프 기기에 대한 수요가 크게 증가하고 있습니다. 심장 질환에 취약한 고령화 인구 증가는 시장 확대에 더욱 기여하고 있습니다. 높은 질병 부담과 더불어 심장 펌프 기술의 발전도 시장을 발전시키고 있습니다. 심장 펌프 기기의 소형화, 내구성 향상, 기능 강화와 같은 기술 혁신은 환자의 예후를 크게 개선하고 채택 증가를 촉진하고 있습니다. 예를 들어, 자기부상 심실보조장치(VAD)(VAD)의 개발은 합병증 위험을 줄이면서 약해진 심장을 더 잘 지원함으로써 시장에 혁명을 일으켰습니다. 심장 펌프 기기 시장에서도 기계식 순환 보조 장치의 채택이 급증하고 있습니다. 진행성 심부전 환자가 증가함에 따라 장기적인 기계적 지원에 대한 수요가 중요해지고 있습니다. 심실보조장치(VAD)(VAD)과 인공심장(TAH)을 포함한 기계식 순환 보조 장치는 심장 이식을 기다리는 환자나 이식이 부적합하다고 판단되는 환자들에게 생명줄을 제공합니다. 기계식 순환보조장치가 이식 부적격 환자의 영구적인 해결책이 될 수 있는 목적지 치료가 점차 받아들여지면서 시장은 더욱 확대되고 있습니다.

목차

주요 요약

  • 시장 개요
  • 전변

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 심장 펌프 기기 시장 : 제품 유형별

  • 시장 개요
  • 보조 심실 장비(VAD)
  • 대동맥내 풍선 펌프(IABP)
  • 완전 인공심장(TAH)

세계의 심장 펌프 기기 시장 : 적응증별

  • 시장 개요
  • Bridge-to-transplant (BTT)
  • Destination therapy (DT)
  • Bridge-to-recovery (BTR)

세계의 심장 펌프 기기 시장 : 최종사용자별

  • 시장 개요
  • 병원
  • 심장병 센터
  • 외래수술센터(ASC)

세계의 심장 펌프 기기 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Abbott Laboratories(미국)
  • Medtronic PLC(아일랜드)
  • LivaNova PLC(영국)
  • Berlin Heart GmbH(독일)
  • SynCardia Systems, LLC(미국)
  • Abiomed, Inc.(미국)
  • Getinge AB(스웨덴)
  • Terumo Corporation(일본)
  • Teleflex Incorporated(미국)
  • Jarvik Heart, Inc.(미국)
  • Fresenius Medical Care AG & Co. KGaA(독일)
  • Calon Cardio(영국)
  • CardiacAssist, Inc.(미국)
  • BiVACOR Inc.(호주)
  • Leviticus Cardio Ltd.(이스라엘)
  • CARMAT SA(프랑스)
  • FineHeart SA(프랑스)
  • MyLVAD(미국)
  • MicroPort Scientific Corporation(중국)
  • TandemLife, a LivaNova company(미국)
LSH 24.04.11

Global Heart Pump Device Market size was valued at USD 2.09 Billion in 2022 and is poised to grow from USD 2.61 Billion in 2023 to USD 15.32 Billion by 2031, at a CAGR of 24.77% during the forecast period (2024-2031).

The global heart pump device market is witnessing substantial growth on a global scale. Our report encompasses detailed information on the value chain analysis for the Heart Pump Device market, providing manufacturers with insights to gain a competitive edge over the projected period. The primary driving force behind this market growth is the increasing prevalence of cardiovascular diseases on a global scale. As the incidence of heart failure continues to rise, the demand for heart pump devices has seen a significant upswing, given their crucial role in supporting and maintaining heart function in patients with severe cardiac conditions. The expanding aging population, more susceptible to heart ailments, further contributes to the market's expansion. In addition to the high disease burden, advancements in heart pump technology have propelled the market forward. Innovations such as miniaturization, improved durability, and enhanced functionality of heart pump devices have substantially improved patient outcomes, fostering increased adoption. For instance, the development of magnetically levitated ventricular assist devices (VADs) has revolutionized the market by providing better support to weakened hearts while reducing the risk of complications. The heart pump device market is also witnessing a surge in the adoption of mechanical circulatory support devices. With the increasing prevalence of advanced heart failure cases, the demand for long-term mechanical support has become critical. Mechanical circulatory support devices, including ventricular assist devices (VADs) and total artificial hearts (TAHs), offer a lifeline to patients awaiting heart transplantation or those deemed unsuitable candidates for transplantation. The growing acceptance of destination therapy, where mechanical circulatory support devices serve as a permanent solution for patient's ineligible for transplant, has further expanded the market's reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Pump Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Heart Pump Device Market Segmental Analysis

The global Heart Pump Device market can be segmented based on product type, indication, end-user, and region. Based on product type, the market can be divided into ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), total artificial heart (TAH). Based on indication, the market can be categorized into bridge-to-transplant (BTT), destination therapy (DT), bridge-to-recovery (BTR). Based on end-user, the market can be categorized into hospitals, cardiology centers, ambulatory surgical centres. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Heart Pump Device Market

Continuous innovation and ongoing advancements in heart pump technology have notably enhanced the performance and outcomes of these devices. Technological progress has given rise to the development of smaller, more durable, and more efficient heart pump devices, ultimately leading to improved patient comfort and an enhanced quality of life. A notable example is the introduction of magnetically levitated ventricular assist devices (LVADs), which has effectively reduced device-related complications and contributed to improved patient outcomes.

Restraints in the Global Heart Pump Device Market

Heart pump devices are intricate and advanced medical technologies, leading to high manufacturing and acquisition costs. The elevated expenses associated with heart pump devices present a substantial financial burden for patients, healthcare providers, and healthcare systems. Additionally, challenges arise from the limited reimbursement coverage for these devices in certain regions, creating obstacles for patients seeking access to these life-saving technologies.

Market Trends of the Global Heart Pump Device Market

Devices that are compatible with heart pump systems are engineered to work seamlessly, optimizing their performance and ensuring efficient functioning. For instance, advanced control units are capable of providing precise management of pump flow and parameters, contributing to enhanced patient outcomes. Similarly, power sources that are compatible can offer extended battery life and a reliable power supply, thereby minimizing interruptions related to the device. These compatible devices often come equipped with advanced monitoring and data management capabilities, enabling real-time remote monitoring. This capability allows healthcare professionals to track patient status and make more informed decisions.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Heart Pump Device Market by Product Type

  • Market Overview
  • Ventricular assist devices (VADs)
  • Intra-aortic balloon pumps (IABPs)
  • Total artificial heart (TAH)

Global Heart Pump Device Market by Indication

  • Market Overview
  • Bridge-to-transplant (BTT)
  • Destination therapy (DT)
  • Bridge-to-recovery (BTR)

Global Heart Pump Device Market by End-user

  • Market Overview
  • Hospitals
  • cardiology centers
  • ambulatory surgical centers

Global Heart Pump Device Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Berlin Heart GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SynCardia Systems, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abiomed, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jarvik Heart, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care AG & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Calon Cardio (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardiacAssist, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BiVACOR Inc. (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leviticus Cardio Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARMAT SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FineHeart SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MyLVAD (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TandemLife, a LivaNova company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제